Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henrique N P Oliva

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 19, 2023
Effects of exercise intervention on psychotic symptoms: A meta-analysis and hypothetical model of neurobiological mechanismsHenrique N P Oliva, Renato S Monteiro-Junior, Isabela O Oliva, et al.
The American Journal on Addictions|November 5, 2025
Readability, linguistic complexity, and stigma in ChatGPT responses to opioid use disorder FAQs: A comparative analysisVitor M Campos, Daniel L Heringer, Gabriel P A Costa, et al.
Frontiers in Psychiatry|May 18, 2026
Protocol for a systematic review and meta-analysis of the relationship between opioid exposure and dopaminergic measures in humans assessed by nuclear medicine imagingYulia Shatalov, Tiago Paiva Prudente, Henrique N P Oliva, et al.
Journal of Addiction Medicine|May 11, 2026
Contingency Management for Stimulant-Opioid Co-Use: A Systematic Review and Meta-AnalysisOluwole O Jegede, Henrique N P Oliva, Tiago P Prudente, et al.
Frontiers in Psychiatry|September 22, 2025
Pharmacotherapies for stimulant use disorder and co-occurring attention deficit hyperactivity disorder: protocol for a systematic review and a meta-analysisHenrique N P Oliva, Alejandra Pulido-Saavedra, Alisson Paredes-Naveda, et al.
Frontiers in Psychiatry|July 12, 2023
Changes in synaptic markers after administration of ketamine or psychedelics: a systematic scoping reviewSimon Zhornitsky, Henrique N P Oliva, Laura A Jayne, et al.
Drug and Alcohol Dependence|January 28, 2026
Safety, tolerability, and drug-drug interactions of NYX-783 and oxycodone in persons using opioids recreationally: Preliminary results from a randomized, double-blind, placebo-controlled phase 1 studyZachary M Harvanek, Marcella M Mignosa, Razi Kitaneh, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 19, 2023
Effects of exercise intervention on psychotic symptoms: A meta-analysis and hypothetical model of neurobiological mechanismsHenrique N P Oliva, Renato S Monteiro-Junior, Isabela O Oliva, et al.
The American Journal on Addictions|November 5, 2025
Readability, linguistic complexity, and stigma in ChatGPT responses to opioid use disorder FAQs: A comparative analysisVitor M Campos, Daniel L Heringer, Gabriel P A Costa, et al.
Frontiers in Psychiatry|May 18, 2026
Protocol for a systematic review and meta-analysis of the relationship between opioid exposure and dopaminergic measures in humans assessed by nuclear medicine imagingYulia Shatalov, Tiago Paiva Prudente, Henrique N P Oliva, et al.
Journal of Addiction Medicine|May 11, 2026
Contingency Management for Stimulant-Opioid Co-Use: A Systematic Review and Meta-AnalysisOluwole O Jegede, Henrique N P Oliva, Tiago P Prudente, et al.
Frontiers in Psychiatry|September 22, 2025
Pharmacotherapies for stimulant use disorder and co-occurring attention deficit hyperactivity disorder: protocol for a systematic review and a meta-analysisHenrique N P Oliva, Alejandra Pulido-Saavedra, Alisson Paredes-Naveda, et al.
Frontiers in Psychiatry|July 12, 2023
Changes in synaptic markers after administration of ketamine or psychedelics: a systematic scoping reviewSimon Zhornitsky, Henrique N P Oliva, Laura A Jayne, et al.
Drug and Alcohol Dependence|January 28, 2026
Safety, tolerability, and drug-drug interactions of NYX-783 and oxycodone in persons using opioids recreationally: Preliminary results from a randomized, double-blind, placebo-controlled phase 1 studyZachary M Harvanek, Marcella M Mignosa, Razi Kitaneh, et al.
Pageof 1